— Know what they know.
Not Investment Advice
Also trades as: STMN.SW (SIX) · $vol 39M · 0QMV.L (LSE) · $vol 16M · 0QMV.IL (IOB) · $vol 15M · SAUHF (OTC) · $vol 0M

SAUHY OTC

Straumann Holding AG
1W: -7.2% 1M: -7.6% 3M: -19.4% YTD: -7.5% 1Y: +0.4% 3Y: -12.7% 5Y: -46.2%
$10.89
-0.01 (-0.12%)
 
Weekly Expected Move ±3.4%
$10 $11 $11 $11 $12
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 38 · $17.4B mcap · 1.59B float · 0.0033% daily turnover · Short 41% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$17.4B
52W Range9.44-13.613
Volume104
Avg Volume52,573
Beta1.38
Dividend$0.13
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOGuillaume Daniellot
Employees11,824
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2014-12-19
Peter Merian-Weg 12
Basel, BS 4002
CH
41 61 965 11 11
About Straumann Holding AG

Straumann Holding AG is a leading global provider of comprehensive dental solutions, specializing in tooth restoration, replacement, and orthodontic treatment. The company actively engages in the research, development, production, and distribution of a diverse portfolio of dental products. This range encompasses advanced dental implants, precision instruments, CAD/CAM prosthetics, clear orthodontic aligners, biomaterials, and cutting-edge digital technologies. These offerings are designed to facilitate tooth correction, replacement, and restoration, while also playing a role in preventing future tooth loss. Straumann's core product lines include a wide array of dental implant systems, featuring tissue and bone level options crafted from materials like titanium, titanium alloy, and ceramics, alongside specialized mini-implants. The company also supplies a full suite of surgical instruments, both guided and non-guided, vital for implant procedures, as well as various implant-supported prosthetics. It excels in digital dentistry, offering sophisticated intraoral scanning solutions, 3D printers, and milling machines. Complementing these are ceramic healing and screw-retained abutments, and a selection of preventative oral care products. A significant part of its portfolio is dedicated to biomaterials, including bone substitutes, specialized membranes, biologics, and products for soft tissue management and enhanced oral healing. Digital solutions extend to dental laboratories, clinics, and central milling facilities, supported by a range of materials, third-party system integrations, and guided surgery technologies. Its comprehensive surgical instrument catalog features modular and specialized cassettes, implant maintenance tools, bone block fixation sets, bonerings, and titanium pin sets. For patients with complete tooth loss (edentulous patients), Straumann provides specialized solutions like pro arch fixed prosthetics and mini implant systems. The company also focuses on aesthetic restorations, offering ceramic implant monotypes, ceramic implants, and various abutments, often enhanced by biologics. Its offerings further include the Clear Correct aligner system for orthodontic correction, and Emdogain, a product designed for wound healing. Beyond products, Straumann is committed to professional development, providing extensive training and educational services to its client base. Straumann's diverse clientele includes general dentists, dental specialists, and technicians working in laboratories. It also serves corporate entities such as distributors, hospitals, universities, and large dental service organizations. Its products reach customers in approximately 100 countries, facilitated by a robust network of direct distribution subsidiaries and strategic partners. Established in 1954, Straumann Holding AG maintains its corporate headquarters in Basel, Switzerland.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms